DeMedic
  • šŸ“šExecutive Summary
  • šŸ“–Introduction
  • šŸ•¶ļøThe DeMedic Vision
  • šŸ“€Core Features
    • Patient Data Ownership & Consent Control
    • DMEDI Token Utility
    • Peer-to-Peer Marketplace Architecture
    • Incentivized Participation Model
    • Researcher Access & Analytics Tools
    • Privacy, Encryption, and Compliance Standards
  • šŸ”§How It Works
    • Patient Onboarding and Data Contribution
    • Researcher Access Workflow
    • Data Privacy and Integrity Mechanisms
    • Ecosystem Flow: Data → Consent → Token → Utility
    • Incentive Alignment & Feedback Loop
  • šŸ’°Tokenomics
    • Token Overview
    • Token Utility
    • Token Distribution
    • Economic Design Principles
    • Future Staking & DAO Features
  • šŸ–±ļøUse Cases
    • Clinical Research Acceleration
    • Real-World Evidence (RWE) for Drug Development
    • Public Health Surveillance & Crisis Response
    • AI Training for Health Diagnostics
    • Personalized Health Insights for Users
    • Ethical Monetization of Health Data
    • Medical Crowdsourcing & Patient-Led Research
  • šŸ Community & Governance
    • A Collaborative Community
    • Governance Model
    • Engagement Incentives
    • Open Ecosystem Philosophy
  • šŸ”Security, Privacy & Compliance
    • Privacy by Design
    • End-to-End Encryption
    • Zero-Knowledge Proofs (ZKPs)
    • Differential Privacy
    • Identity & Access Management
    • Smart Contract Security
    • Data Sovereignty and User Controls
    • Regulatory Compliance
  • šŸ›£ļøRoadmap
    • Phase 1: Foundation & MVP (Q2 2025)
    • Phase 2: Early Ecosystem & Onboarding (Q3 2025)
    • Phase 3: Growth & Monetization (Q4 2025)
    • Phase 4: Decentralization & DAO Transition (Q1–Q2 2026)
    • Phase 5: Global Rollout & Institutional Adoption (Mid–Late 2026)
    • Ongoing: Innovation & Resilience
  • šŸ“‘Conclusion
Powered by GitBook
On this page
  • The Problem: Centralized Health Data and Limited Access
  • The Opportunity: Patient-Owned, Permissioned, and Tokenized Health Data

Introduction

The Problem: Centralized Health Data and Limited Access

For decades, health data has been locked away in hospital systems, research institutions, and corporate databases. Despite being generated by patients, this information is often inaccessible to the very individuals it concerns. Worse still, this data is routinely sold to third parties—insurance companies, pharmaceutical firms, and analytics platforms—without transparent consent or fair compensation.

This centralized control not only creates ethical concerns but also slows down scientific progress. Researchers face immense barriers in accessing diverse, high-quality, real-world data needed for cutting-edge medical studies. The result? Delayed treatments, underserved communities, and stagnant innovation.

The Opportunity: Patient-Owned, Permissioned, and Tokenized Health Data

DeMedic is built to solve these systemic issues by turning the data ownership model on its head. Instead of patients passively giving up their data, DeMedic allows them to own, manage, and monetize it. Using blockchain and smart contracts, every transaction is traceable, verifiable, and secured—ensuring data is only shared with explicit consent.

The platform serves as a neutral, decentralized layer where patients can upload or link their health records—from electronic health records (EHRs) and genetic reports to fitness trackers and wearable data—and get rewarded in $DMEDI tokens for sharing that data with verified research projects.

This paradigm shift in data management transforms a passive resource into an active asset. It builds trust, reduces barriers for researchers, and accelerates discovery—all while preserving patient rights and privacy.

PreviousExecutive SummaryNextThe DeMedic Vision

Last updated 1 month ago

šŸ“–